Touitou E, Illum L. Nasal drug delivery. Drug Deliv Transl Res. 2013;3:1–3.
Dey S, Mahanti B, Mazumder B, Malgope A, Sandeepan A, Dasgupta. Nasal drug delivery: an approach of drug delivery through nasal route. Der Chem Sinica. 2011;2:94–106.
Ozsoy Y, Gungor S, Cevher E. Nasal delivery of high molecular weight drugs. Molecules [Internet]. 2009 [cited 2024 Sep 19];14:3754–79. Available from: https://pubmed.ncbi.nlm.nih.gov/19783956/
Permana AD, Ramadhan Aziz AY, Sam A, Djabir YY, Arsyad MA, Harahap Y et al. Development of hyaluronic acid-based microneedles for improved brain delivery of Rivastigmine nanoparticles via mystacial pad region. J Drug Deliv Sci Technol. 2023;90.
Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life sci. Elsevier Inc.; 2018. pp. 44–52.
Zuckerman M, Weisberg SN, Boyer EW. Pitfalls of intranasal naloxone. Prehospital emergency care [Internet]. 2014 [cited 2023 Apr 9]; 18:550–4. Available from: https://pubmed.ncbi.nlm.nih.gov/24830404/
Basu, S., Holbrook, L.T., Kudlaty, K. et al. Numerical evaluation of spray position for improved nasal drug delivery. Sci Rep 10, 10568 (2020).https://doi.org/10.1038/s41598-020-66716-0
Ruan S, Li J, Ruan H, Xia Q, Hou X, Wang Z, et al. Microneedle-mediated nose-to-brain drug delivery for improved alzheimer’s disease treatment. J Controlled Release. 2024;366:712–31.
Dali P, Shende P. Use of 3D applicator for intranasal microneedle arrays for combinational therapy in migraine. Int J Pharm. 2023;635.
Dali P, Shende P. Use of 3D applicator for intranasal microneedle arrays for combinational therapy in migraine. Int J Pharm. 2023;635:122714.
Tijani A, Dogra P, Peláez MJ, Wang Z, Cristini V, Puri A. Mechanistic modeling-guided optimization of microneedle-based skin patch for rapid transdermal delivery of naloxone for opioid overdose treatment. Drug Deliv Transl Res [Internet]. 2022 [cited 2022 Dec 4]; Available from: https://pubmed.ncbi.nlm.nih.gov/35879533/
Henriques P, Bicker J, Carona A, Miranda M, Vitorino C, Doktorovová S, et al. Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics. J Pharm Investig. 2023;53:723–42.
Peláez MJ, Ruiz-Ramírez J, Shen Y, Birur RM, Schiavone C, Cristini V et al. Mechanistic modeling for optimal design of dissolvable microneedle-based patches for transdermal drug delivery. Annu Int Conf IEEE Eng Med Biol Soc [Internet]. 2023 [cited 2024 Jan 2];2023:1–4. Available from: https://pubmed.ncbi.nlm.nih.gov/38082979/
Tijani AO, Connors D, Schiavone C, Peláez MJ, Dogra P, Puri A. Iontophoresis-coupled rapidly dissolving polymeric microneedle patch of naloxone for its enhanced transdermal delivery. Int J Pharm [Internet]. 2024 [cited 2024 Sep 19];660. Available from: https://pubmed.ncbi.nlm.nih.gov/38825171/
Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res [Internet]. 2011 [cited 2024 Sep 19];2:215. Available from: /pmc/articles/PMC3255357/
Mygind N, Dahl R. Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Deliv Rev. 1998;29:3–12.
Krieter PA, Chiang CN, Gyaw S, McCann DJ. Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device. The Journal of Clinical Pharmacology [Internet]. 2019 [cited 2022 Mar 15];59:1078–84. Available from: https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1002/jcph.1401
RR T, IA T, F A-S, AA A. H M, RF D. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery. Drug Deliv Transl Res [Internet]. 2016 [cited 2021 Jul 26];6:800–15. Available from: https://pubmed.ncbi.nlm.nih.gov/27709355/
Ruan S, Zhang Y, Feng N. Microneedle-mediated transdermal nanodelivery systems: a review. Biomater Sci [Internet]. 2021 [cited 2023 Aug 9];9:8065–89. Available from: https://pubs.rsc.org/en/content/articlehtml/2021/bm/d1bm01249e
Toomey D, Boyer EW, Naloxone. History of Modern Clinical Toxicology [Internet]. 2024 [cited 2024 Sep 19];265–70. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441910/
Naloxone - StatPearls. - NCBI Bookshelf [Internet]. [cited 2024 Sep 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441910/
Ganeson K, Alias AH, Murugaiyah V, Amirul AAA, Ramakrishna S, Vigneswari S. Microneedles for Efficient and Precise Drug Delivery in Cancer Therapy. Pharmaceutics [Internet]. 2023 [cited 2024 Sep 19];15. Available from: /pmc/articles/PMC10057903/
Barry BW. Breaching the skin’s barrier to drugs [Internet]. Nat Biotechnol. Nature Publishing Group; 2004 [cited 2021 Apr 21]. pp. 165–7. Available from: https://www.nature.com/articles/nbt0204-165
Jeong SH, Jang JH, Lee YB. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. Journal of Pharmaceutical Investigation 2022 53:1 [Internet]. 2022 [cited 2024 Sep 19];53:119–52. Available from: https://link.springer.com/article/10.1007/s40005-022-00589-5
Fortuna A, Alves G, Serralheiro A, Sousa J, Falcão A. Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules. Eur J Pharm Biopharm. 2014;88:8–27.
Arpa MD, Okur NÜ, Gök MK, Cevher E. Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of Tizanidine hydrochloride by bypassing the first-pass metabolism. J Drug Deliv Sci Technol. 2024;97:105739.
Botelho da Silva S, Krolicka M, van den Broek LAM, Frissen AE, Boeriu CG. Water-soluble Chitosan derivatives and pH-responsive hydrogels by selective C-6 oxidation mediated by TEMPO-laccase redox system. Carbohydr Polym. 2018;186:299–309.
Liu Q, Li X, Liu B, Kong J, Wang Q, Gao Z. Using Polymers as Crystal Inhibitors to Prevent the Crystallization of the Rotigotine Patch. Pharmaceutics 2024, Vol 16, Page 630 [Internet]. 2024 [cited 2024 Oct 7];16:630. Available from: https://www.mdpi.com/1999-4923/16/5/630/htm.
Comments (0)